Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8058 USD | +2,65% | +0,60% | -32,85% |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 2,59 mln. 2,42 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | - | Nettowinst (verlies) 2024 * | - | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,1
x | K/w-verhouding 2024 * |
-0,11
x | Werknemers | 18 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 95,63% |
Recentste transcriptie over Eloxx Pharmaceuticals, Inc.
1 dag | +2,65% | ||
1 week | +0,60% | ||
Lopende maand | -19,42% | ||
1 maand | -5,20% | ||
3 maanden | -3,50% | ||
6 maanden | -50,56% | ||
Lopend jaar | -32,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 01-11-20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 08-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 01-05-14 |
Alan Walts
BRD | Director/Board Member | 64 | 01-04-21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 01-04-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,8058 | +2,65% | 1 985 |
25-04-24 | 0,785 | -3,09% | 1 165 |
24-04-24 | 0,81 | -1,82% | 1 251 |
23-04-24 | 0,825 | +2,80% | 6 670 |
22-04-24 | 0,8025 | +0,19% | 1 669 |
uitgestelde koers OTC Markets, 26 april 2024 om 20:34 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-32,85% | 2,59 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |